Nodal Marginal Zone Lymphoma — Trials

Nodal Marginal Zone Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

138 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 10
Recruiting: 6
Ph III recruiting: 0
Growth YoY: —
Industry share: 10%
Top sponsor: City of Hope Medical Center
Termination share: 38.9%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (34)

clinicaltrialsPublishedShowing 51–72 of 72 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00019708	Geldanamycin Analogue in Treating Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma	terminated	Phase 1	45	National Cancer Institute (NCI)NIH	1	Dec 16, 2013	clinicaltrials
NCT00068315	Bortezomib and Fludarabine With or Without Rituximab in Treating Patients With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia	completed	Phase 1	18	National Cancer Institute (NCI)NIH	1	Sep 30, 2013